Microbot Medical Inc.
MBOT Nasdaq
SEC CIK 883975
Follow Microbot Medical
Weekly email: filings, results
Revenue, last quarter
$72K
Net income
−$5.8M
−63.3% vs same quarter last year
EPS, diluted
−$0.09
−28.6% vs same quarter last year
Operating cash flow
−$5.4M
−40.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$13.1M |
| FY24 | - | −$11.4M |
| FY23 | - | −$10.7M |
| FY22 | - | −$13.2M |
| FY21 | - | −$11.3M |
| FY20 | - | −$9.2M |
| FY19 | - | −$7.2M |
| FY18 | - | −$7.3M |
| FY17 | - | −$7.6M |
| FY16 | - | - |
| FY15 | $116.9K | −$921K |
| FY14 | $1M | −$1.2M |
| FY13 | $172.3K | −$26.4M |
| FY12 | $1.4M | −$28.5M |
| FY11 | $1.2M | −$21.3M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | - | - | - |
| FY23 | - | - | - |
| FY22 | - | - | - |
| FY21 | - | - | - |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | 782.8% | −787.9% |
| FY14 | - | −107.4% | −119.2% |
| FY13 | −83.8% | −16304.8% | −15345.1% |
| FY12 | 80.8% | −1601.5% | −2082.8% |
| FY11 | 82.4% | −2300.1% | −1747.3% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$13.1M |
| FY24 | −$8.9M |
| FY23 | −$8.6M |
| FY22 | −$11.6M |
| FY21 | −$9.4M |
| FY20 | −$7.3M |
| FY19 | −$6.7M |
| FY18 | −$5.5M |
| FY17 | −$4.9M |
| FY16 | −$811K |
| FY15 | −$767K |
| FY14 | −$27.4M |
| FY13 | −$28M |
| FY12 | −$19.9M |
| FY11 | −$22.4M |
- Microbot Medical
- Healthcare median
Show the numbers
| Year | Microbot Medical | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | - | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.8% |
| FY20 | - | −62.2% |
| FY19 | - | −46.2% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | −787.9% | −37.8% |
| FY14 | −119.2% | −35.5% |
| FY13 | −15345.1% | −37.1% |
| FY12 | −2082.8% | −29.1% |
| FY11 | −1747.3% | −27.9% |